Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis
We demonstrated that osteoporosis is associated with a preferential type II muscle fiber atrophy, which correlates with bone mineral density and reduced levels of Akt, a major regulator of muscle mass. In osteoarthritis, muscle atrophy is of lower extent and related to disease duration and severity.
Osteoarthritis (OA) and osteoporosis (OP) are associated with loss of muscle bulk and power. In these diseases, morphological studies on muscle tissue are lacking, and the underlying mechanisms of muscle atrophy are not known. The aim of our study was to evaluate the OP- or OA-related muscle atrophy and its correlation with severity of disease. Muscle levels of Akt protein, a component of IGF-1/PI3K/Akt pathway, the main regulator of muscle mass, have been determined.
We performed muscle biopsy in 15 women with OP and in 15 women with OA (age range, 60–85 years). Muscle fibers were counted, measured, and classified by ATPase reaction. By statistical analysis, fiber-type atrophy was correlated with bone mineral density (BMD) in the OP group and with Harris Hip Score (HHS) and disease duration in the OA group. Akt protein levels were evaluated by Western blot analysis.
Our findings revealed in OP a preferential type II fiber atrophy that inversely correlated with patients’ BMD. In OA, muscle atrophy was of lower extent, homogeneous among fiber types and related to disease duration and HHS. Moreover, in OP muscle, the Akt level was significantly reduced as compared to OA muscles.
This study shows that in OP, there is a preferential and diffuse type II fiber atrophy, proportional to the degree of bone loss, whereas in OA, muscle atrophy is connected to the functional impairment caused by the disease. A reduction of Akt seems to be one of the mechanisms involved in OP-related muscle atrophy.
- Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3–S11 CrossRef
- Duque G, Troen BR (2008) Understanding the mechanisms of senile osteoporosis: new facts for a major geriatric syndrome. J Am Geriatr Soc 56:935–941 CrossRef
- Tarantino U, Capone A, Planta M, D’Arienzo M, Letizia Mauro G, Impagliazzo A, Formica A, Pallotta F, Patella V, Spinarelli A, Pazzaglia U, Zarattini G, Roselli M, Montanari G, Sessa G, Privitera M, Verdoia C, Corradini C, Feola M, Padolino A, Saturnino L, Scialdoni A, Rao C, Iolascon G, Brandi ML, Piscitelli P (2010) The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study. Arthritis Res Ther 12:R226 CrossRef
- Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, Jones G (2005) A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthr Cartil 13:769–781 CrossRef
- Walsh MC, Hunter GR, Livingstone MB (2006) Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density. Osteoporos Int 17:61–67 CrossRef
- Scott D, Blizzard L, Fell J, Jones G (2012) A prospective study of self-reported pain, radiographic osteoarthritis, sarcopenia progression and falls risk in community-dwelling older adults. Arthritis Care Res (Hoboken) 64:30–37 CrossRef
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M (2010) European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423 CrossRef
- Lexell J (1995) Human aging, muscle mass, and fiber type composition. Gerontol A Biol Sci Med Sci 50:S11–S16
- Joseph C, Kenny AM, Taxel P, Lorenzo JA, Duque G, Kuchel GA (2005) Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk. Mol Aspects Med 26:181–201 CrossRef
- Perrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, Giorgino F (2010) The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol 205:201–210 CrossRef
- Glass DJ (2010) Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care 13:225–229 CrossRef
- Morley JE (2008) Sarcopenia: diagnosis and treatment. Nutr Health Aging 12:452–456 CrossRef
- Andreoli A, Celi M, Volpe SL, Sorge R, Tarantino U (2012) Long-term effect of exercise on bone mineral density and body composition in post-menopausal ex-elite athletes: a retrospective study. Eur J Clin Nutr 66:69–74 CrossRef
- Harris WH (1969) Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am 51:737–755
- Pisani V, Panico MB, Terracciano C, Bonifazi E, Meola G, Novelli G, Bernardi G, Angelini C, Massa R (2008) Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2. Muscle Nerve 38:1405–1411 CrossRef
- Brooke MH, Engel WK (1969) The histographic analysis of human muscle biopsies with regard to fiber types: 2. Diseases of the upper and lower motor neuron. Neurology 19:378–393 CrossRef
- Dubowitz V, Sewry CA (2007) Muscle biopsy: a practical approach, 3rd edn. Saunders, Elsevier, New York, pp 75–123 CrossRef
- Terracciano C, Nogalska A, Engel WK, Askanas V (2010) In AbetaPP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AbetaPP751 and GSK3beta activation: effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositis. J Neurochem 112:389–396 CrossRef
- Sato Y, Inose M, Higuchi I, Higuchi F, Kondo I (2002) Changes in the supporting muscles of the fractured hip in elderly women. Bone 30:325–330 CrossRef
- Schakman O, Gilson H, Thissen JP (2008) Mechanisms of glucocorticoid-induced myopathy. Endocrinology 197:1–10 CrossRef
- Morley JE, Thomas DR, Wilson MM (2006) Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83:735–743
- Sun Z, Liu L, Liu N, Liu Y (2008) Muscular response and adaptation to diabetes mellitus. Front Biosci 13:4765–4794 CrossRef
- Frost RA, Lang CH (2007) Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. J Appl Physiol 103:378–387 CrossRef
- Jennekens FG, Tomlinson BE, Walton JN (1971) Histochemical aspects of five limb muscles in old age. An autopsy study. J Neurol Sci 14:259–276 CrossRef
- Sĭrca A, Susec-Michieli M (1980) Selective type II fibre muscular atrophy in patients with osteoarthritis of the hip. J Neurol Sci 44:149–159 CrossRef
- Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Volume 24, Issue 3 , pp 1095-1100
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Muscle atrophy
- Type II fibers
- Industry Sectors
- Author Affiliations
- 1. Department of Neurosciences, Tor Vergata University of Rome, Via Montpellier, 1, 00133, Rome, Italy
- 2. Department of Orthopedics and Traumatology, Tor Vergata University of Rome, Rome, Italy
- 3. IRCSS Fondazione S. Lucia, Rome, Italy